Yeon‐Jeong Kim

University of Yamanashi — Japan

Immunology and Microbiology · Life Sciences

34h-index3.5kcitations122works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune cells in cancer(25), Immune Cell Function and Interaction(22), Immunotherapy and Immune Responses(18), CAR-T cell therapy research(11), Cancer therapeutics and mechanisms(8)

Publications122 total

4-Phenylbutyric Acid Improves Gait Ability of UBAP1-Related Spastic Paraplegia Mouse Model: Therapeutic Potential for SPG80
International Journal of Molecular Sciences·2025Open Access
Exploring Trends in Healthcare Open Source Software on GitHub: LLM-Based Topic Augmentation and Network Analysis
Journal of Intelligence and Information Systems·2025Open Access
Genetic and clinical landscape of Chinese frontotemporal dementia: dominance of TBK1 and OPTN mutations
Alzheimer s Research & Therapy·2024· 8 citedOpen Access
A light-controlled phospholipase C for imaging of lipid dynamics and controlling neural plasticity
Cell chemical biology·2024· 7 citedOpen Access
Case report: Reversible brain atrophy with low titer anti-amphiphysin antibodies related to gastric adenocarcinoma
Frontiers in Neurology·2023· 3 citedOpen Access
Increased PDGFRB and NF-κB signaling caused by highly prevalent somatic mutations in intracranial aneurysms
Science Translational Medicine·2023· 21 cited
Abstract 1347: PAUF stimulates monocytes and induces their differentiation into tumor-associated macrophages
Cancer Research·2023
Data from CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity <i>In vivo</i>
2023Open Access
Supplementary Figure 3 from A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2023Open Access
Supplementary Figure Legends 1-4 from A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2023Open Access
Supplementary Figure 1 from A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2023Open Access
Data from Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
2023Open Access
Data from Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
2023Open Access
Supplementary Figures from Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
2023Open Access
Data from A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2023Open Access
Supplementary Figure 2 from A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2023Open Access
Supplementary Figures S1-S3 from CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity <i>In vivo</i>
2023Open Access
Supplementary Figure 2 from A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2023Open Access
Data from CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity <i>In vivo</i>
2023Open Access
Supplementary Figures S1-S3 from CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity <i>In vivo</i>
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Chang‐Yuil Kang(14), Hyun‐Jeong Ko(13), Yoshio Hirabayashi(6), Yun-Sun Kim(5), Jung-Mi Lee(5), Roger D. Kornberg(4), Sung‐Youl Ko(4), Cheorl‐Ho Kim(4), Young‐Choon Lee(4), Woo‐Sung Chang(3), Kyoo‐A Lee(3), Yeonseok Chung(3), Ryōsuke Takahashi(3), Dong‐Hyeon Kim(3), Seongyea Jo(3), Eun‐Soo Kwon(3), Song Cheol Kim(3), Sang Seok Koh(3), Stefan Björklund(2), Sun‐Young Chang(2)